Phase 1/2 clinical trial for OTO-313 in tinnitus patients
Phase of Trial: Phase I/II
Latest Information Update: 11 Feb 2019
At a glance
- Drugs Gacyclidine (Primary)
- Indications Tinnitus
- Focus Adverse reactions; Therapeutic Use
- 11 Feb 2019 Planned initiation date changed to 1 Apr 2019.
- 06 Feb 2019 According to an Otonomy media release, trial details will be presented at Association for Research in Otolaryngology Annual Meeting 2019.
- 03 Jan 2019 According to an Otonomy media release, the trial is expected to start in the second quarter of 2019 with results in the first half of 2020.